Nicole Haubst

This inventor holds 10 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignee: Novartis Ag. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicole Haubst. Retrieved from https://idiyas.com/inventor/nicole-haubst

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10 (Patent Applications = 12)

% Patents Active = 60.0

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 3 (Patent Applications = 12)

Average Co-Inventor Count = 8.7

ph-index = 5

Forward Citations = 58(Granted Patents)

Company Filing History:

10 out of 3,979

Novartis Ag

patents

Years Active: 2014-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12570733 - ANTI-BETACELLULIN ANTIBODIES, FRAGMENTS THEREOF, AND MULTI-SPECIFIC BINDING MOLECULES (2026-03-10),

2. 11524998 - Anti-betacellulin antibodies, fragments thereof, and multi-specific binding molecules (2022-12-13),

3. 10745473 - Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules (2020-08-18),

4. 10080800 - Antibodies for epidermal growth factor receptor 3 (HER3) (2018-09-25),

5. 10077317 - Antibodies for epidermal growth factor receptor 3 (HER3) (2018-09-18),

6. 10000561 - Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules (2018-06-19),

7. 9498532 - Antibody drug conjugates (2016-11-22),

8. 9415118 - Antibody drug conjugates (2016-08-16),

9. 9192663 - Antibodies for epidermal growth factor receptor 3 (HER3) (2015-11-24),

10. 8735551 - Antibodies for epidermal growth factor receptor 3 (HER3) (2014-05-27),

Title: Nicole Haubst: Innovator in Antibody Research

Introduction

Nicole Haubst is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody therapies. With a total of 10 patents to her name, her work has the potential to impact various medical applications.

Latest Patents

Among her latest patents, Nicole has developed anti-betacellulin antibodies, fragments thereof, and multi-specific binding molecules. This patent provides anti-BTC antibodies, methods of producing these antibodies, pharmaceutical compositions comprising these antibodies, and methods of using them. Additionally, she has worked on thymic stromal lymphopoietin (TSLP)-binding molecules, which include antibodies or antibody fragments that specifically bind TSLP, along with compositions and methods for their use and production.

Career Highlights

Nicole Haubst is currently employed at Novartis AG, a leading global healthcare company. Her role involves extensive research and development in the field of antibody therapies, where she applies her expertise to create innovative solutions for medical challenges.

Collaborations

Throughout her career, Nicole has collaborated with notable colleagues, including Seth Alexander Ettenberg and Andrew Paul Garner. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Nicole Haubst is a trailblazer in the field of antibody research, with a strong portfolio of patents that reflect her innovative spirit. Her contributions continue to advance the understanding and application of therapeutic antibodies in medicine.

Profile summary based on public USPTO records.